Abstract:Objective: To investigate the effects of advanced glycation end products (AGEs) on the proliferation and apoptosis of cardiac microvascular endothelial cells (CMECs) in rats and their underlying signaling pathway. Methods: CMECs were isolated from Sprague-Dawley rats. We first examined the effects of AGEs on the proliferation and apoptosis of CMECs and then tested whether protein kinase C (PKC) beta blockers could counteract the effects of AGEs. The PKC agonists phorbol 12-myristate 13-acetate (PMA) and PKC beta blockers were also used to verify whether PKC could act independently on CMECs. The receptor for AGEs (RAGE)-small interfering RNA (siRNA) transfection was used to verify the effect of AGEs on PKC. Following the above steps, we explained whether AGEs regulated the CMEC proliferation and early apoptosis through the PKC beta signaling pathway. Proliferation of CMECs was detected using the Cell Counting Kit-8 (CCK-8) assay, and early apoptosis was determined using the Annexin V- Fluorescein Isothiocyanate (FITC)/propidium iodide (PI) double staining. Expression of proliferation and apoptosis-related proteins and PKC phosphorylation were determined by western blotting analysis. Cell cycle distributions were assayed using a BD FACSCalibur cell-sorting system. Results: AGEs facilitated the proliferation of CMECs, upregulated phosphorylated extracellular signal regulated kinase (p-ERK), and accelerated the entry of cells from G1 phase to the S+G2/M phase, which was consistent with the upregulated cyclin D1 by AGEs. AGEs inhibited early apoptosis of CMECs by increasing the expression of survivin and decreasing the expression of cleaved-caspase3. All these effects can be reversed by PKC beta 1/2inhibitors. In addition, AGE upregulated the RAGE expression and phosphorylation of PKC beta 1/2 in CMECs, while the inhibition of RAGE reversed the phosphorylation, as well as the effects of AGEs on proliferation and apoptosis in CMECs. Conclusion: The study indicated that AGEs facilitated the proliferation and reduced early apoptosis of CMECs via the PKC beta signaling pathway.

Inhibition Effect of Puerarin on the Formation of Advanced Glycosylation End Products in Peritoneal Dialysis Solution in Vitro

Inhibitory Effects of Hydroxysafflor Yellow A on the Formation of Advanced Glycation End Products in Vitro.

Investigation of Inhibition of Thrombospondin-1 ( TSP-1 ) Expression by Puerarin in Kidney of Diabetic

[Experimental Factors Affecting in Vitro Recovery of Puerarin in Microdialysis].

Accumulation of Tissue Advanced Glycation End Products Correlated with Glucose Exposure Dose and Associated with Cardiovascular Morbidity in Patients on Peritoneal Dialysis

Advanced Glycation End Products Facilitate Proliferation and Reduce Early Apoptosis of Cardiac Microvascular Endothelial Cell Via PKCβ Signaling Pathway: Insight from Diabetic Cardiomyopathy

Puerarin protects the cultured human peritoneal mesothelial cells from the damage caused by peritoneal dialysate

The Effect of DongMeiYin on Advanced Glycation End Products in the Renal Cortex of Early Diabetic Nephropathy Rats

Analysis of influencing factors of advanced glycation end products peptides in serum in continuous ambulatory peritoneal dialysis non-diabetic patients

Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis

Effect of Puerarin on Oxidative Stress in Continuous Ambulatory Peritoneal Dialysis Patients

Inhibitory effect of pycnogenol on generation of advanced glycation end products in vitro

Effects of Puerarin on Early Diabetic Nephropathy

Inhibition of Highland Barley Bran-Derived Carbon Dots on the Formation of Advanced Glycation End Products

Inhibitory Effects of Extracts from {\sl Ginkgo Biloba} and Grape Seed on the Generation of Advanced Glycation End Products {\sl in Vitro}

Inhibition of advanced glycation end product formation by Pu-erh tea ameliorates progression of experimental diabetic nephropathy.

Effect of Glucose Related to Peritoneal Dialysate on the Cell Cycle and Protein P21 Expression in Human Peritoneal Mesothelial Cells and the Antagonism of Puerarin

Puerarin Ameliorates Oxidative Stress in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis

Effects of puerarin on expression of glucose regulated protein78 and apoptosis in cultured human aortic endothelial cells induced by homocysteinemia

The Effect of Puerarin on the Oxidative Stress in Cultured Human Peri-toneal Mesothelial Cells

Effects of Advanced Glycation End Products on the Cultured Rabbit Retinal Müller Cells